Komure K, Goldstein G, Boyse E A
J Immunol. 1975 Jul;115(1):195-8.
It was established previously that committed precursors of T cells, which reside in bone marrow and spleen and lack T cell surface differentiation antigens, can be induced by thymopoietin and certain other agents to differentiate rapidly in vitro into T cells bearing typical surface antigens, including Thy-1 and TL (Komuro-Boyse assay). To relate this differentiative step observed in vitro to physiologic events in vivo, a system was devised to trace the migration of precursor cells to the thymus, and their maturation to T cells. Lethally irradiated mice of a TL- strain received spleen cells from TL+ hybrids i.v., and the TL+ population of the thymus was enumerated 13 to 20 days later. Donor TL+ cells first became detectable at 13 days and increased thereafter. Preliminary tests showed that cells capable of migrating to the thymus have a similar density to the cells that are inducible in the Komuro-Boyse assay, this being lower than that of mature of T cells. The thymus-repopulating properties of the donor spleen population were not affected by: 1) pre-treatment in vitro with thymus extract or thymopoietin, which initiates differentiation of T cells precursors, nor b) pre-treatment with anti Thy-1 serum plus complement, which eliminates differentiated T cells. But pre-treatment a) and b) applied in sequence markedly reduced the capacity of spleen cells to repopulate the thymus. These results can be interpreted as follows: induction of Thy-1-TL- precursor cells (pro-thymocyte) in vitro yields Thy-1+TL+ cells (early thymocytes) which have not yet lost their property of repopulating the thymus; therefore, thymus-repopulation was not depleted by treatment a) alone, which induced Thy-1 +TL+ cells, nor by treatment b) alone, which did not affect thymus-repopulation by Thy-1-TL- cells, although treatments a) plus b) did eliminate the newly induced Thy-1+TL+ cells and thus impaired repopulation of the thymus. We conclude that the cell which responds to thymopoietin in the Komuro-Boyse assay by expressing the T cell surface phenotype is the same cell (pro-thymocyte) that normally migrates in vivo from hemopoietic tissues to the thymus and is there induced by thymopoietin to express the phenotype of an early T cell.
先前已证实,存在于骨髓和脾脏中且缺乏T细胞表面分化抗原的T细胞定向前体细胞,可被胸腺生成素和某些其他因子诱导,在体外迅速分化为带有典型表面抗原(包括Thy-1和TL,Komuro-Boyse检测法)的T细胞。为了将体外观察到的这一分化步骤与体内的生理事件联系起来,设计了一个系统来追踪前体细胞向胸腺的迁移及其向T细胞的成熟过程。给TL-品系的致死剂量照射小鼠静脉注射来自TL+杂种的脾细胞,并在13至20天后对胸腺中的TL+细胞群体进行计数。供体TL+细胞在13天时首次可检测到,此后数量增加。初步试验表明,能够迁移到胸腺的细胞与Komuro-Boyse检测法中可诱导的细胞密度相似,低于成熟T细胞的密度。供体脾细胞群体的胸腺重建特性不受以下因素影响:1)用胸腺提取物或胸腺生成素进行体外预处理,这会启动T细胞前体的分化;2)用抗Thy-1血清加补体进行预处理,这会消除分化的T细胞。但是依次进行预处理a)和b)会显著降低脾细胞重建胸腺的能力。这些结果可以如下解释:体外诱导Thy-1-TL-前体细胞(原胸腺细胞)产生Thy-1+TL+细胞(早期胸腺细胞),这些细胞尚未丧失其重建胸腺的特性;因此,单独用处理a)诱导Thy-1 +TL+细胞不会耗尽胸腺重建能力,单独用处理b)不影响Thy-1-TL-细胞的胸腺重建能力,尽管处理a)加b)确实消除了新诱导的Thy-1+TL+细胞,从而损害了胸腺的重建。我们得出结论,在Komuro-Boyse检测法中通过表达T细胞表面表型对胸腺生成素作出反应的细胞,与正常情况下在体内从造血组织迁移到胸腺并在那里被胸腺生成素诱导表达早期T细胞表型的细胞(原胸腺细胞)是同一细胞。